MedTrace Logo

Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results

NCT00004091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-01-31

No results posted yet for this study

Summary

RATIONALE: Examining biomarkers in abnormal cervical cells may improve the ability to detect these cells and plan effective treatment.

PURPOSE: Diagnostic trial to detect specific biomarkers in abnormal cervical cells in women who have abnormal Pap test results.

Conditions

Interventions

OTHER

Papanicolaou test

OTHER

cytology specimen collection procedure

OTHER

fluorescent antibody technique

PROCEDURE

colposcopic biopsy

PROCEDURE

study of high risk factors

Sponsors & Collaborators

Principal Investigators

  • Phillip Y. Roland, MD · Florida Gynecologic Oncology - Fort Myers

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-08-31
Primary Completion
2001-02-28
Completion
2001-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004091 on ClinicalTrials.gov